Jef Van Dam serves as the Chief Executive Officer of De Ceunynck Radiotherapy, a pivotal subsidiary of the De Ceunynck Medical Group, where he leverages over 30 years of international experience in the medical technology industry. Under his leadership, the company is at the forefront...
Jef Van Dam serves as the Chief Executive Officer of De Ceunynck Radiotherapy, a pivotal subsidiary of the De Ceunynck Medical Group, where he leverages over 30 years of international experience in the medical technology industry. Under his leadership, the company is at the forefront of commercializing cutting-edge radiotherapy solutions, including the innovative ViewRay MRIdian-Linac and the ZAP Surgical system, which is a dedicated, self-shielded SRS device. Jef’s expertise in sales and marketing, coupled with his extensive background in general management and distribution management, has been instrumental in driving the successful launch and adoption of these advanced technologies within the oncology landscape.
Jef is adept at building and leading high-performing international teams, fostering a culture of collaboration and innovation that is essential for navigating the complexities of the healthcare market. His strategic planning skills are complemented by a deep understanding of product management and commercialization processes, enabling him to effectively position De Ceunynck Radiotherapy as a leader in the industry. Key projects under his guidance include the development of strategic partnerships with healthcare providers and research institutions, aimed at enhancing clinical outcomes through the integration of advanced radiotherapy solutions.
Moreover, Jef's commitment to organizational development and change management ensures that the company remains agile and responsive to the evolving needs of the oncology sector. His proficiency in ISO 13485 standards and clinical research further underscores his capability to drive quality and compliance in product development, ultimately contributing to improved patient care and outcomes. As De Ceunynck Radiotherapy continues to expand its footprint in the global market, Jef Van Dam's visionary leadership will be crucial in shaping the future of radiotherapy technology.
